Neuronetics Q4 Earnings Call Highlights [Yahoo! Finance]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
continuing its strategy to operate a vertically integrated mental-health company combining NeuroStar technology and Greenbrook clinics. Fourth-quarter total revenue was $41.8 million (up 86% YoY; +23% adjusted pro forma) and the company reported positive operating cash flow in Q4; 2026 guidance calls for $160–166 million in revenue with full-year operating cash flow expected to be negative $13M–$17M but turning positive in the second half. Operational momentum includes strong Greenbrook growth (clinic revenue +28% pro forma, referrals and patient starts up meaningfully, Spravato available at 84 clinics and combined Spravato/TMS volumes +18% YoY) alongside robust NeuroStar performance (49 systems shipped in Q4, ASP above target and over 420 BMP provider sites). Interested in Neuronetics, Inc.? Here are five stocks we like better. Neuronetics (NASDAQ:STIM) reported fourth-quarter 2025 financial and operating results highlighted by its first full year operating with the Greenbroo
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Neuronetics (STIM) had its price target lowered by Canaccord Genuity Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.MarketBeat
- Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch [Seeking Alpha]Seeking Alpha
- Neuronetics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Neuronetics (STIM) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 3/17/26 - Beat
STIM
Analyst Actions
- 3/19/26 - Canaccord Genuity
STIM
Sec Filings
- 3/19/26 - Form 144
- 3/19/26 - Form 144
- 3/18/26 - Form 4
- STIM's page on the SEC website